Research Base

Protocols
General Information
Accruals
Member Area

98308: A Phase III Randomized, Double-Blind, Placebo Controlled Trial of North American Ginseng Extract (CVT-E002; COLD-fX®) to Prevent Respiratory Infection and Reduce Antibiotic Use in Patients with Chronic Lymphocytic Leukemia (1 credit)

This study is permanently closed as of 01/01/2009. The accrual goal has been achieved.

Appendices • Archived Amendments • Adverse Events

Quick Reference

Research Base

Local

336-716-0891

E-mail
Patient Registration
Comprehensive Cancer Center
Office of Research

Locate Faculty

First Name Last Name Department

Ways to Give

Disclaimer: The information on this Web site is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.